Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLendinvest Regulatory News (LINV)

Share Price Information for Lendinvest (LINV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.00
Bid: 28.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.143%)
Open: 29.00
High: 29.00
Low: 29.00
Prev. Close: 29.00
LINV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Portfolio Sale

20 Sep 2021 17:44

RNS Number : 3738M
LendInvest PLC
20 September 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

LEI: 213800NWMK3O4UWP9N91

 

20th September 2021

 

LendInvest plc

 

("LendInvest" or "the Company")

 

£100m Buy-to-Let Sale to J.P. Morgan

 

LendInvest plc (LSE: LINV), the leading technology driven asset manager for property finance, is pleased to announce the sale of a £100m Buy-to-Let portfolio to J.P. Morgan.

 

Highlights:

· The portfolio will sit within J.P. Morgan's Separate Account Mandate and will increase the total Separate Account capacity from £625m to £725m.

· The portfolio sale will generate a net increase of profit before tax for the current financial year of £1.6m.

· The transaction is in line with LendInvest's strategy of transferring assets under management originated via our Genesys platform into third party accounts and fund structures, and similar transactions may be carried out in future.

· Whilst the sale will bring forward certain profits arising from the first half of the 2023 financial year into the current financial year, the Board remains confident with current market expectations for FY23 and beyond.

 

Background:

In January 2021 LendInvest completed the establishment of a Separate Account Mandate with J.P. Morgan with a total capacity of £625m. This investment in our Buy-to-Let product expands our capacity to lend in this market, while providing J.P. Morgan with exposure to Buy-to-Let mortgages which have been originated via LendInvest's proprietary technology platform.

LendInvest has an ongoing arrangement with J.P. Morgan to allocate a portion of monthly Buy-to-Let originations to its Separate Account. This transaction transfers £100m of previously originated Buy-to-Let loans into that Separate Account, growing its capacity from £625m to £725m. The consideration being paid by J.P. Morgan is in line with the existing terms of the ongoing arrangement, as described in the Company's AIM Admission Document, together with an incremental payment of £1.67m.

This sale is representative of the growing appetite of global institutions to invest in mortgages through LendInvest. It follows our announcement in August 2021 where we reported a £150m partnership with Barclays and HSBC to provide short-term finance to property entrepreneurs around the UK.

 

Rod Lockhart, Chief Executive of LendInvest, commented:

"I am very pleased to be able to announce this transaction so soon after our IPO. The sale is an opportunity to deepen our Separate Account with J.P. Morgan, made possible by strong market conditions and good performance in our Buy-to-Let portfolio over recent months.

It is representative of our continued momentum in attracting some of the world's most sophisticated investors. Genesys, our proprietary technology platform, and broker-focused model allows LendInvest to efficiently originate property finance loans, providing partners with access to an asset class with attractive risk-adjusted returns.

This transaction reflects our intentions at IPO to move more assets off our balance sheet over time, seek to take these profitable opportunities when they present themselves, and strengthen our funds management business model."

 

- Ends -

 

Enquiries:

 

LendInvest via Tulchan Communications

Rod Lockhart, Chief Executive Officer +44 20 7353 4200

Michael Evans, Chief Financial Officer

Leigh Rimmer, Senior PR Manager

investorrelations@lendinvest.com

Berenberg (Nominated Advisor and Broker) +44 20 3207 7800

Alex Reynolds

Jack Botros

 

Tulchan Communications (Financial PR) +44 20 7353 4200

Tom Murray

Matt Low

 

Important Notices

The information contained within this announcement is deemed by LendInvest to constitute inside information as stipulated under the UK Market Abuse Regulation. By the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this announcement on behalf of LendInvest is Rod Lockhart.

The information contained in this announcement is for information purposes only. This announcement has been prepared in accordance with English law, the UK Market Abuse Regulation and the AIM Rules for Companies and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

Subject to the requirements of the UK Market Abuse Regulation and the AIM Rules for Companies, the delivery of this announcement shall not create any implication that there has been no change in the affairs of LendInvest since the date of this announcement or that the information in this announcement is correct as at any time subsequent to its date.

Forward-looking statements

Certain statements in this announcement are forward-looking statements. In some cases, these forward looking statements can be identified by the use of forward looking terminology including the terms "anticipate", "believe", "intend", "estimate", "expect", "may", "will", "seek", "continue", "aim", "target", "projected", "plan", "goal", "achieve" and words of similar meaning or in each case, their negative, or other variations or comparable terminology. These forward looking statements reflect LendInvest's current expectations concerning future events and speak only as of the date of this announcement. No statement in this announcement is intended as a profit forecast or estimate for any period.

 

Many factors may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Important factors that could cause actual results, performance or achievements of the Company to differ materially from the expectations of the Company, include, among other things, general business and economic conditions globally, industry trends, competition, changes in government and changes in regulation and policy, including in relation to the environment, health and safety and taxation, labour relations and work stoppages, interest rates and currency fluctuations, changes in its business strategy, political and economic uncertainty and other factors. Such forward-looking statements should therefore be construed in light of such factors. Neither the Company nor any of its Directors, officers or advisers provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEDFMSEFSELU
12
Date   Source Headline
4th Jun 20249:58 amRNSBoard Changes
4th Jun 20247:01 amRNSLendInvest successfully closes funding transaction
4th Jun 20247:00 amRNSBoard Changes
18th Apr 20247:00 amRNSTrading Update
9th Feb 20245:23 pmRNSBlock Listing Six Monthly Return
26th Jan 202410:17 amRNSDirector/PDMR Notification
24th Jan 20247:00 amRNSPDMR dealing
5th Jan 20247:00 amRNSSale of residual economic interest in RMBS
19th Dec 20237:00 amRNSInterim Financial Results
30th Nov 20237:00 amRNSAnnouncement of Securitisation Settlement
22nd Nov 20234:42 pmRNSAnnouncement of Securitisation Transaction
4th Oct 20237:00 amRNSNotification of transactions by PCA with PDMR
28th Sep 202310:54 amRNSPublication of Final Terms
28th Sep 20238:19 amRNSFinal Terms Confirmation
22nd Sep 202310:26 amRNSIssue of shares to EBT and Total Voting Rights
18th Sep 202312:05 pmRNSResults of AGM
13th Sep 20231:23 pmRNSLaunch of 11.5% Bonds due 2026 and Exchange Offer
12th Sep 20231:42 pmRNSPublication of Base Prospectus
8th Sep 20239:57 amRNSConclusion of IT security event
5th Sep 202310:30 amRNSTrading update
4th Sep 202310:00 amRNSRoadshow announcement
25th Aug 20237:00 amRNSNotice of data breach
11th Aug 20238:59 amRNSBlock listing Interim Review
10th Aug 20231:55 pmRNSHolding(s) in Company
10th Aug 20231:47 pmRNSHolding(s) in Company
7th Aug 20234:28 pmRNSHolding(s) in Company
7th Aug 20234:26 pmRNSDirector/PDMR Notification
18th Jul 20237:00 amRNSLendInvest plc Full Year Financial Results FY23
3rd Jul 20237:00 amRNSAnnouncement of £500 million funding partnership
30th May 20237:00 amRNSLendInvest sells Buy-to-Let mortgage portfolio
5th May 202312:07 pmRNSPDMR Exercise of Share Options
5th May 202311:53 amRNSDirectorate Change
19th Apr 20233:22 pmRNSSale of residual economic interest in RMBS
13th Apr 20237:00 amRNSTrading Update
22nd Mar 202311:40 amRNSIssue of Shares to EBT and Total Voting Rights
1st Mar 20234:47 pmRNSSale of residual economic interest in RMBS
13th Feb 20237:00 amRNSBlock Listing Six Monthly Return
3rd Feb 20234:24 pmRNSDirector/PDMR Notification
17th Jan 20237:00 amRNSLendInvest secures funding from Lloyds Bank
19th Dec 20224:18 pmRNSNew £100 million financial partnership
19th Dec 20227:00 amRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Financial Results
14th Oct 202210:41 amRNSDirector/PDMR Shareholding
11th Oct 202210:09 amRNSDirector/PDMR Shareholding
10th Oct 20227:00 amRNSTrading Update
8th Sep 20224:02 pmRNSResult of AGM
16th Aug 202210:56 amRNSPDMR Exercise of Share Options
12th Aug 20221:29 pmRNSSale of residual economic interest in RMBS
12th Aug 20227:00 amRNSBlock Listing Six Monthly Return
5th Aug 20227:55 amRNSNotice of Annual General Meeting
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.